- Ongoing, recruitingTherapeutic use (Phase IV)
A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents aged 6 to 17 Years with Attention-deficit/Hyperactivity Disorder
This study is looking at a medicine called Intuniv for children and teenagers aged 6 to 17 with ADHD. We want to see how safe and effective it is compared to another medicine and a dummy pill, and find the best dose.
For: Attention-deficit/hyperactivity disorder (ADHD)Sweden · Netherlands · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
This study is testing a new medicine, cenobamate, for people in the UK and other countries who have a specific type of epilepsy seizure called Primary Generalized Tonic-Clonic seizures. Researchers want to see if it reduces how often these seizures happen and if it's safe to use.
For: Primary Generalized Tonic-Clonic SeizuresSlovakia · Hungary · Spain